{"id":"https://openalex.org/W2079928697","doi":"https://doi.org/10.1021/ml300168e","title":"Discovery of DS-8108b, a Novel Orally Bioavailable Renin Inhibitor","display_name":"Discovery of DS-8108b, a Novel Orally Bioavailable Renin Inhibitor","publication_year":2012,"publication_date":"2012-08-18","ids":{"openalex":"https://openalex.org/W2079928697","doi":"https://doi.org/10.1021/ml300168e","mag":"2079928697","pmid":"https://pubmed.ncbi.nlm.nih.gov/24900544","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4025657"},"language":"en","primary_location":{"id":"doi:10.1021/ml300168e","doi":"https://doi.org/10.1021/ml300168e","is_oa":false,"landing_page_url":"https://doi.org/10.1021/ml300168e","pdf_url":null,"source":{"id":"https://openalex.org/S191852912","display_name":"ACS Medicinal Chemistry Letters","issn_l":"1948-5875","issn":["1948-5875"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","jufo-1","ki-jl-1","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS Medicinal Chemistry Letters","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4025657","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103799158","display_name":"Yuji Nakamura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104626","display_name":"Daiichi-Sankyo (Japan)","ror":"https://ror.org/027y26122","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104626"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yuji Nakamura","raw_affiliation_strings":["Lead Discovery & Optimization Research Laboratories I, \u2021Lead Discovery & Optimization Research Laboratories II, \u00a7Cardiovascular-Metabolics Research Laboratories, \u2225Biological Research Laboratories, \u22a5Drug Metabolism & Pharmacokinetics Research Laboratories, and #Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lead Discovery & Optimization Research Laboratories I, \u2021Lead Discovery & Optimization Research Laboratories II, \u00a7Cardiovascular-Metabolics Research Laboratories, \u2225Biological Research Laboratories, \u22a5Drug Metabolism & Pharmacokinetics Research Laboratories, and #Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan","institution_ids":["https://openalex.org/I4210104626"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033181869","display_name":"Teppei Fujimoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104626","display_name":"Daiichi-Sankyo (Japan)","ror":"https://ror.org/027y26122","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104626"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Teppei Fujimoto","raw_affiliation_strings":["Lead Discovery & Optimization Research Laboratories I, \u2021Lead Discovery & Optimization Research Laboratories II, \u00a7Cardiovascular-Metabolics Research Laboratories, \u2225Biological Research Laboratories, \u22a5Drug Metabolism & Pharmacokinetics Research Laboratories, and #Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lead Discovery & Optimization Research Laboratories I, \u2021Lead Discovery & Optimization Research Laboratories II, \u00a7Cardiovascular-Metabolics Research Laboratories, \u2225Biological Research Laboratories, \u22a5Drug Metabolism & Pharmacokinetics Research Laboratories, and #Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan","institution_ids":["https://openalex.org/I4210104626"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068931344","display_name":"Yasuyuki Ogawa","orcid":"https://orcid.org/0009-0000-6013-6119","observed_orcids":["https://orcid.org/0009-0000-6013-6119"]},"institutions":[{"id":"https://openalex.org/I4210104626","display_name":"Daiichi-Sankyo (Japan)","ror":"https://ror.org/027y26122","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104626"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasuyuki Ogawa","raw_affiliation_strings":["Lead Discovery & Optimization Research Laboratories I, \u2021Lead Discovery & Optimization Research Laboratories II, \u00a7Cardiovascular-Metabolics Research Laboratories, \u2225Biological Research Laboratories, \u22a5Drug Metabolism & Pharmacokinetics Research Laboratories, and #Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lead Discovery & Optimization Research Laboratories I, \u2021Lead Discovery & Optimization Research Laboratories II, \u00a7Cardiovascular-Metabolics Research Laboratories, \u2225Biological Research Laboratories, \u22a5Drug Metabolism & Pharmacokinetics Research Laboratories, and #Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan","institution_ids":["https://openalex.org/I4210104626"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069131884","display_name":"Chie Sugita","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104626","display_name":"Daiichi-Sankyo (Japan)","ror":"https://ror.org/027y26122","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104626"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Chie Sugita","raw_affiliation_strings":["Lead Discovery & Optimization Research Laboratories I, \u2021Lead Discovery & Optimization Research Laboratories II, \u00a7Cardiovascular-Metabolics Research Laboratories, \u2225Biological Research Laboratories, \u22a5Drug Metabolism & Pharmacokinetics Research Laboratories, and #Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lead Discovery & Optimization Research Laboratories I, \u2021Lead Discovery & Optimization Research Laboratories II, \u00a7Cardiovascular-Metabolics Research Laboratories, \u2225Biological Research Laboratories, \u22a5Drug Metabolism & Pharmacokinetics Research Laboratories, and #Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan","institution_ids":["https://openalex.org/I4210104626"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112084939","display_name":"Shojiro Miyazaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104626","display_name":"Daiichi-Sankyo (Japan)","ror":"https://ror.org/027y26122","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104626"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shojiro Miyazaki","raw_affiliation_strings":["Lead Discovery & Optimization Research Laboratories I, \u2021Lead Discovery & Optimization Research Laboratories II, \u00a7Cardiovascular-Metabolics Research Laboratories, \u2225Biological Research Laboratories, \u22a5Drug Metabolism & Pharmacokinetics Research Laboratories, and #Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lead Discovery & Optimization Research Laboratories I, \u2021Lead Discovery & Optimization Research Laboratories II, \u00a7Cardiovascular-Metabolics Research Laboratories, \u2225Biological Research Laboratories, \u22a5Drug Metabolism & Pharmacokinetics Research Laboratories, and #Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan","institution_ids":["https://openalex.org/I4210104626"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110033371","display_name":"Kazuhiko Tamaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104626","display_name":"Daiichi-Sankyo (Japan)","ror":"https://ror.org/027y26122","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104626"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazuhiko Tamaki","raw_affiliation_strings":["Lead Discovery & Optimization Research Laboratories I, \u2021Lead Discovery & Optimization Research Laboratories II, \u00a7Cardiovascular-Metabolics Research Laboratories, \u2225Biological Research Laboratories, \u22a5Drug Metabolism & Pharmacokinetics Research Laboratories, and #Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lead Discovery & Optimization Research Laboratories I, \u2021Lead Discovery & Optimization Research Laboratories II, \u00a7Cardiovascular-Metabolics Research Laboratories, \u2225Biological Research Laboratories, \u22a5Drug Metabolism & Pharmacokinetics Research Laboratories, and #Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan","institution_ids":["https://openalex.org/I4210104626"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015284443","display_name":"Mizuki Takahashi","orcid":"https://orcid.org/0000-0002-6238-9838","observed_orcids":["https://orcid.org/0000-0002-6238-9838"]},"institutions":[{"id":"https://openalex.org/I4210104626","display_name":"Daiichi-Sankyo (Japan)","ror":"https://ror.org/027y26122","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104626"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mizuki Takahashi","raw_affiliation_strings":["Lead Discovery & Optimization Research Laboratories I, \u2021Lead Discovery & Optimization Research Laboratories II, \u00a7Cardiovascular-Metabolics Research Laboratories, \u2225Biological Research Laboratories, \u22a5Drug Metabolism & Pharmacokinetics Research Laboratories, and #Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lead Discovery & Optimization Research Laboratories I, \u2021Lead Discovery & Optimization Research Laboratories II, \u00a7Cardiovascular-Metabolics Research Laboratories, \u2225Biological Research Laboratories, \u22a5Drug Metabolism & Pharmacokinetics Research Laboratories, and #Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan","institution_ids":["https://openalex.org/I4210104626"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070095749","display_name":"Yumi Matsui","orcid":"https://orcid.org/0000-0003-3901-0225","observed_orcids":["https://orcid.org/0000-0003-3901-0225"]},"institutions":[{"id":"https://openalex.org/I4210104626","display_name":"Daiichi-Sankyo (Japan)","ror":"https://ror.org/027y26122","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104626"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yumi Matsui","raw_affiliation_strings":["Lead Discovery & Optimization Research Laboratories I, \u2021Lead Discovery & Optimization Research Laboratories II, \u00a7Cardiovascular-Metabolics Research Laboratories, \u2225Biological Research Laboratories, \u22a5Drug Metabolism & Pharmacokinetics Research Laboratories, and #Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lead Discovery & Optimization Research Laboratories I, \u2021Lead Discovery & Optimization Research Laboratories II, \u00a7Cardiovascular-Metabolics Research Laboratories, \u2225Biological Research Laboratories, \u22a5Drug Metabolism & Pharmacokinetics Research Laboratories, and #Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan","institution_ids":["https://openalex.org/I4210104626"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Takahiro Nagayama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104626","display_name":"Daiichi-Sankyo (Japan)","ror":"https://ror.org/027y26122","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104626"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takahiro Nagayama","raw_affiliation_strings":["Lead Discovery & Optimization Research Laboratories I, \u2021Lead Discovery & Optimization Research Laboratories II, \u00a7Cardiovascular-Metabolics Research Laboratories, \u2225Biological Research Laboratories, \u22a5Drug Metabolism & Pharmacokinetics Research Laboratories, and #Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lead Discovery & Optimization Research Laboratories I, \u2021Lead Discovery & Optimization Research Laboratories II, \u00a7Cardiovascular-Metabolics Research Laboratories, \u2225Biological Research Laboratories, \u22a5Drug Metabolism & Pharmacokinetics Research Laboratories, and #Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan","institution_ids":["https://openalex.org/I4210104626"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kenichi Manabe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104626","display_name":"Daiichi-Sankyo (Japan)","ror":"https://ror.org/027y26122","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104626"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kenichi Manabe","raw_affiliation_strings":["Lead Discovery & Optimization Research Laboratories I, \u2021Lead Discovery & Optimization Research Laboratories II, \u00a7Cardiovascular-Metabolics Research Laboratories, \u2225Biological Research Laboratories, \u22a5Drug Metabolism & Pharmacokinetics Research Laboratories, and #Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lead Discovery & Optimization Research Laboratories I, \u2021Lead Discovery & Optimization Research Laboratories II, \u00a7Cardiovascular-Metabolics Research Laboratories, \u2225Biological Research Laboratories, \u22a5Drug Metabolism & Pharmacokinetics Research Laboratories, and #Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan","institution_ids":["https://openalex.org/I4210104626"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011126050","display_name":"Makoto Mizuno","orcid":"https://orcid.org/0000-0002-2300-1618","observed_orcids":["https://orcid.org/0000-0002-2300-1618"]},"institutions":[{"id":"https://openalex.org/I4210104626","display_name":"Daiichi-Sankyo (Japan)","ror":"https://ror.org/027y26122","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104626"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Makoto Mizuno","raw_affiliation_strings":["Lead Discovery & Optimization Research Laboratories I, \u2021Lead Discovery & Optimization Research Laboratories II, \u00a7Cardiovascular-Metabolics Research Laboratories, \u2225Biological Research Laboratories, \u22a5Drug Metabolism & Pharmacokinetics Research Laboratories, and #Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lead Discovery & Optimization Research Laboratories I, \u2021Lead Discovery & Optimization Research Laboratories II, \u00a7Cardiovascular-Metabolics Research Laboratories, \u2225Biological Research Laboratories, \u22a5Drug Metabolism & Pharmacokinetics Research Laboratories, and #Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan","institution_ids":["https://openalex.org/I4210104626"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061679683","display_name":"Noriko Masubuchi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104626","display_name":"Daiichi-Sankyo (Japan)","ror":"https://ror.org/027y26122","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104626"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Noriko Masubuchi","raw_affiliation_strings":["Lead Discovery & Optimization Research Laboratories I, \u2021Lead Discovery & Optimization Research Laboratories II, \u00a7Cardiovascular-Metabolics Research Laboratories, \u2225Biological Research Laboratories, \u22a5Drug Metabolism & Pharmacokinetics Research Laboratories, and #Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lead Discovery & Optimization Research Laboratories I, \u2021Lead Discovery & Optimization Research Laboratories II, \u00a7Cardiovascular-Metabolics Research Laboratories, \u2225Biological Research Laboratories, \u22a5Drug Metabolism & Pharmacokinetics Research Laboratories, and #Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan","institution_ids":["https://openalex.org/I4210104626"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046959175","display_name":"Katsuyoshi Chiba","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104626","display_name":"Daiichi-Sankyo (Japan)","ror":"https://ror.org/027y26122","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104626"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Katsuyoshi Chiba","raw_affiliation_strings":["Lead Discovery & Optimization Research Laboratories I, \u2021Lead Discovery & Optimization Research Laboratories II, \u00a7Cardiovascular-Metabolics Research Laboratories, \u2225Biological Research Laboratories, \u22a5Drug Metabolism & Pharmacokinetics Research Laboratories, and #Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lead Discovery & Optimization Research Laboratories I, \u2021Lead Discovery & Optimization Research Laboratories II, \u00a7Cardiovascular-Metabolics Research Laboratories, \u2225Biological Research Laboratories, \u22a5Drug Metabolism & Pharmacokinetics Research Laboratories, and #Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan","institution_ids":["https://openalex.org/I4210104626"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088154545","display_name":"Takahide Nishi","orcid":"https://orcid.org/0000-0002-6222-9711","observed_orcids":["https://orcid.org/0000-0002-6222-9711"]},"institutions":[{"id":"https://openalex.org/I4210104626","display_name":"Daiichi-Sankyo (Japan)","ror":"https://ror.org/027y26122","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104626"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Takahide Nishi","raw_affiliation_strings":["Lead Discovery & Optimization Research Laboratories I, \u2021Lead Discovery & Optimization Research Laboratories II, \u00a7Cardiovascular-Metabolics Research Laboratories, \u2225Biological Research Laboratories, \u22a5Drug Metabolism & Pharmacokinetics Research Laboratories, and #Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lead Discovery & Optimization Research Laboratories I, \u2021Lead Discovery & Optimization Research Laboratories II, \u00a7Cardiovascular-Metabolics Research Laboratories, \u2225Biological Research Laboratories, \u22a5Drug Metabolism & Pharmacokinetics Research Laboratories, and #Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan","institution_ids":["https://openalex.org/I4210104626"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5088154545"],"corresponding_institution_ids":["https://openalex.org/I4210104626"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":1.8573,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.87232694,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"3","issue":"9","first_page":"754","last_page":"758"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/renin-inhibitors","display_name":"renin inhibitors","score":0.9169999957084656},{"id":"https://openalex.org/keywords/orally-bioavailable-drugs","display_name":"orally bioavailable drugs","score":0.800000011920929},{"id":"https://openalex.org/keywords/plasma-renin-activity","display_name":"plasma renin activity","score":0.8410000205039978},{"id":"https://openalex.org/keywords/antihypertensive-effect","display_name":"antihypertensive effect","score":0.7239999771118164},{"id":"https://openalex.org/keywords/blood-pressure-reduction","display_name":"blood pressure reduction","score":0.8069999814033508},{"id":"https://openalex.org/keywords/cynomolgus-monkeys","display_name":"Macaca fascicularis","score":0.824999988079071},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8659999966621399},{"id":"https://openalex.org/keywords/drug-synthesis","display_name":"drug synthesis","score":0.46399998664855957}],"concepts":[{"id":"https://openalex.org/C2777425892","wikidata":"https://www.wikidata.org/wiki/Q409255","display_name":"Renin inhibitor","level":4,"score":0.8572292327880859},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7977221012115479},{"id":"https://openalex.org/C138976137","wikidata":"https://www.wikidata.org/wiki/Q7201790","display_name":"Plasma renin activity","level":4,"score":0.7919522523880005},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.7908246517181396},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7667601108551025},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.757125973701477},{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.7384810447692871},{"id":"https://openalex.org/C2777752497","wikidata":"https://www.wikidata.org/wiki/Q286779","display_name":"IC50","level":3,"score":0.6983503103256226},{"id":"https://openalex.org/C198710026","wikidata":"https://www.wikidata.org/wiki/Q898218","display_name":"Renin\u2013angiotensin system","level":3,"score":0.637123167514801},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.5243616104125977},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5216187238693237},{"id":"https://openalex.org/C2777955127","wikidata":"https://www.wikidata.org/wiki/Q388801","display_name":"Furosemide","level":2,"score":0.5100527405738831},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.48645612597465515},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.472316712141037},{"id":"https://openalex.org/C17077164","wikidata":"https://www.wikidata.org/wiki/Q1185869","display_name":"Inhibitory postsynaptic potential","level":2,"score":0.4525243639945984},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3348693549633026},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.22963321208953857},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.15427979826927185},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1316821575164795},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1021/ml300168e","doi":"https://doi.org/10.1021/ml300168e","is_oa":false,"landing_page_url":"https://doi.org/10.1021/ml300168e","pdf_url":null,"source":{"id":"https://openalex.org/S191852912","display_name":"ACS Medicinal Chemistry Letters","issn_l":"1948-5875","issn":["1948-5875"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","jufo-1","ki-jl-1","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS Medicinal Chemistry Letters","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3020222","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4025657","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:24900544","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24900544","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS medicinal chemistry letters","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4025657","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4025657/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS Med Chem Lett","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:3020222","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4025657","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1480141326","https://openalex.org/W1705716610","https://openalex.org/W1966923357","https://openalex.org/W1970010625","https://openalex.org/W1970939791","https://openalex.org/W1980977337","https://openalex.org/W1982790476","https://openalex.org/W1990304872","https://openalex.org/W2001175007","https://openalex.org/W2015793109","https://openalex.org/W2016250761","https://openalex.org/W2018457457","https://openalex.org/W2021232559","https://openalex.org/W2050686897","https://openalex.org/W2066517589","https://openalex.org/W2083919220","https://openalex.org/W2097638191","https://openalex.org/W2114193904","https://openalex.org/W2128921112","https://openalex.org/W2171146813","https://openalex.org/W2410133262","https://openalex.org/W2915298571","https://openalex.org/W2952738961"],"related_works":["https://openalex.org/W2151200548","https://openalex.org/W2031074049","https://openalex.org/W2030304485","https://openalex.org/W2147355520","https://openalex.org/W2111873497","https://openalex.org/W2333349729","https://openalex.org/W2125121133","https://openalex.org/W2143534082","https://openalex.org/W2047672761","https://openalex.org/W2093774213"],"abstract_inverted_index":{"A":[0],"novel":[1],"orally":[2],"bioavailable":[3],"renin":[4,10,31,42,65],"inhibitor,":[5],"DS-8108b":[6],"(5),":[7],"showing":[8],"potent":[9],"inhibitory":[11,32,61],"activity":[12,33,43],"and":[13,25,50,70,72,78,89,110],"excellent":[14],"in":[15,34,45,54,94,106],"vivo":[16,40,108],"efficacy":[17],"is":[18],"described.":[19],"We":[20],"report":[21],"herein":[22],"the":[23],"synthesis":[24],"pharmacological":[26],"effects":[27,37,53],"of":[28,38,84,87,92,113],"5":[29,59,93],"including":[30],"vitro,":[35],"suppressive":[36],"ex":[39,107],"plasma":[41],"(PRA)":[44],"cynomolgus":[46,95],"monkey,":[47],"pharmacokinetic":[48],"data,":[49],"blood":[51,116],"pressure-lowering":[52],"an":[55],"animal":[56],"model.":[57],"Compound":[58],"demonstrated":[60],"activities":[62],"toward":[63],"human":[64,71],"(IC50":[66,75],"=":[67,76],"0.9":[68],"nM)":[69],"monkey":[73,96],"PRA":[74,109],"1.9":[77],"6.3":[79],"nM,":[80],"respectively).":[81],"Oral":[82],"administration":[83],"single":[85],"doses":[86],"3":[88],"10":[90],"mg/kg":[91],"on":[97],"pretreatment":[98],"with":[99],"furosemide":[100],"led":[101],"to":[102],"dose-dependent":[103],"significant":[104],"reductions":[105],"sustained":[111],"lowering":[112],"mean":[114],"arterial":[115],"pressure":[117],"for":[118],"more":[119],"than":[120],"12":[121],"h.":[122]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}